| Title: | Letter: Major Adverse Outcomes in Steatotic Liver Disease Subtypes - From Etiological Classification to Biological Phenotyping: Authors' Reply |
| Journal: | Alimentary Pharmacology & Therapeutics |
| Published: | 2 Aug 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42543783/ |
| DOI: | https://doi.org/10.1111/apt.70900 |
Publication 21237
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
2 Authors
- Takao Miwa
- Bernd Schnabl
1 Application
| Application ID | Title |
|---|---|
| 930515 | Unveiling the outcomes and developing targeted therapies in chronic liver disease |
Enabling scientific discoveries that improve human health